Company Deep Dive

Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.

View Deep Dive

MRV.TO

BUY

Marvell Technology, Inc. · Healthcare · $26.8B · Avg Vol: $4M/d

75
StockRank
Get insider-trade alerts
Q
69
V
75
M
25
P/E (TTM)
8.8x
ROE
18.7%
D/E
0.3x
Dividend %
0.0%
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Marvell Technology, Inc. is a pharmaceutical company engaged in the research, development, and commercialization of novel therapeutic agents. The company focuses on addressing unmet medical needs through its proprietary drug discovery platform and clinical-stage pipeline. It operates as a niche pharmaceutical player seeking to secure strategic licensing agreements and development partnerships with global healthcare firms.

FINANCIAL SUMMARY (USD)

Year2023202420252026CAGRTTM
Revenue5.9B5.5B5.8B8.2B11.4%8.2B
EPS-0.19-1.08-1.023.10——
Shares856.1M865.5M866.0M847.3M-1.0%875.8M
Debt4.7B4.4B4.3B4.8B0.4%4.8B
Equity15.6B14.8B13.4B14.3B-2.9%—
Op CF1.3B1.4B1.7B1.8B10.7%1.8B
Inv CF-328.4M-350.5M-300.7M2.1B——
Fin CF-662.9M-980.2M-1.4B-2.2B——
Loading 1Y...
PRICE (1Y)-31.9%
23.6427.0130.3833.7637.13Jun 3Jun 24Jul 15
Close
$23.64
RSI (14)
31.4

SCORE BREAKDOWN

Quality
69
ROIC
17.5%89.4
ROE
18.7%87.3
GP/Assets
18.8%44.8
Op. Margin
16.3%77.5
FCF/Assets
7.5%78.7
Piotroski
893.4
Int. Cover
8.0x57.5
D/E Ratio
0.33x39.5
Current Ratio
2.01x38.0
Value
75
P/E (TTM)
8.8x91.4
EV/EBITDA
5.4x90.7
P/FCF
16.1x73.8
P/B
0.9x86.6
P/S
2.8x58.6
Div Yield
0.0%0.1
Momentum
25
52W High %
—N/A
RS 6M
—N/A
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$26.8B
P/E (Forward)
—
Gross Margin
51.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MRV.TO are excluded.

TickerCompanyMkt CapStockRankSignal
MRV.TOMarvell Technology, Inc.(you)$26.8B75BUY

Marvell Technology, Inc. (MRV.TO) — Stock Score Summary

Marvell Technology, Inc. (MRV.TO) has a MoatMap StockRank of 75/100 based on Quality (69/100), Value (75/100), and Momentum (25/100) factor scores. The current signal is BUY.

Marvell Technology, Inc. is a pharmaceutical company engaged in the research, development, and commercialization of novel therapeutic agents. The company focuses on addressing unmet medical needs through its proprietary drug discovery platform and clinical-stage pipeline. It operates as a niche pharmaceutical player seeking to secure strategic licensing agreements and development partnerships with global healthcare firms.

Key Financial Metrics

Price$23.64
Market Cap$26.8B
P/E (TTM)8.84
Price/Book0.87
Return on Equity18.7%
Return on Invested Capital17.5%
Debt/Equity0.33x
Gross Margin51.0%
Operating Margin16.3%
Dividend Yield0.0%
Free Cash Flow$1.7B

Marvell Technology, Inc. operates in the Pharmaceuticals industry, part of the Healthcare sector.

Frequently Asked Questions

What is Marvell Technology, Inc.’s (MRV.TO) StockRank?
MoatMap’s StockRank for Marvell Technology, Inc. (MRV.TO) is 75/100, with a Buy signal. It is a composite of Quality (69), Value (75), and Momentum (25) factor ranks across MoatMap’s 20,000+ stock universe.
Does Marvell Technology, Inc. have an economic moat?
Marvell Technology, Inc. (MRV.TO) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Marvell Technology, Inc. a buy, hold, or sell?
MoatMap’s current signal for Marvell Technology, Inc. (MRV.TO) is Buy, based on a StockRank of 75/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Marvell Technology, Inc. in?
Marvell Technology, Inc. (MRV.TO) operates in the Healthcare sector, specifically the Pharmaceuticals industry.
Browse all ranked stocksMRV.TO deep dive reportAI ChampionsHow we score stocksSense-check another stock